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Abstract
Lysozymes are antimicrobial enzymes that perform a critical role in resisting infection in a wide-range of eukaryotes.
However, using the nematode Caenorhabditis elegans as a model host we now demonstrate that deletion of the
protist type lysozyme LYS-7 renders animals susceptible to killing by the fatal fungal human pathogen Cryptococcus
neoformans, but, remarkably, enhances tolerance to the enteric bacteria Salmonella Typhimurium. This trade-off
in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys-7 and the tyrosine
kinase abl-1. Together this implies a greater complexity in C. elegans innate immune function than previously
thought.
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Introduction
The nematode Caenorhabditis elegans is now firmly established as a
powerful model system for the study of host-pathogen interactions
[1,2,3]. Although many aspects of innate immunity are shared
with higher vertebrates [4], nematodes lack a cell-mediated
immune system and thus rely upon secreted antimicrobial
molecules for a systemic immune response to pathogenic challenge
[2].
One such group of antimicrobial enzymes, lysozymes, are
evolutionarily ancient proteins that are actively lytic against a
range of microbes [5]. Whereas many organisms have only one or
two lysozyme genes, C. elegans has a family of at least ten
differentially regulated genes that are predicted to show significant
functional diversity [6,7]. Within the C. elegans lysozyme family, lys-
7 has been the most extensively studied. Expression of this
molecule is strongly induced upon exposure of the animal to the
pathogenic bacteria Serratia marcescens [8], Microbacterium nematophi-
lum [9] and Salmonella Typhimurium [10]. Furthermore, lys-7
knockout animals show enhanced susceptibility to M. nemato-
philum, indicating that lys-7 has a protective function against this
pathogen [9].
Here we examine the function of LYS-7 during C. elegans
infection with a number of human pathogens. Surprisingly, we
show that LYS-7 acts together with the tyrosine kinase ABL-1 to
regulate an immunological balance in which resistance to C.
neoformans comes at the cost of susceptibility to S. Typhimurium.
Since this phenotype is independent of infectious burden or disease
persistence, our data suggest a novel function of LYS-7 in
regulating pathogen tolerance in C. elegans.
Results
lys-7 mutant animals are hyper-susceptible to killing by
Cryptococcus neoformans
We, and others, have previously shown that the fatal fungal
human pathogen Cryptococcus neoformans kills C. elegans [11,12]. A
preliminary gene expression study of two C. elegans strains, daf-
2(e1370) and fem-1(hc17)IV, that are intrinsically resistant to killing
by the fungus revealed that lys-7 expression was strongly and
constitutively induced in these animals (R. C. May, unpublished
data). We therefore hypothesised that LYS-7 may play an
important role in mediating resistance of the worm towards C.
neoformans. In line with this prediction, a lys-7 knockout strain
(ok1384) showed wild type brood size and longevity under non-
infectious conditions (Figs S1A and B; Methods S1), but severely
reduced survival following exposure to the fungus (Fig 1A).
lys-7 mutant animals are resistant to killing by Salmonella
Typhimurium
In order to establish whether the loss of LYS-7 influenced
immunity to other pathogens, we exposed lys-7 knockout animals
to three organisms previously shown to be pathogenic towards C.
elegans; the Gram-positive bacterium Staphylococcus aureus [13] and
two Gram-negative bacteria Pseudomonas aeruginosa [14,15,16] and
Salmonella enterica serovar Typhimurium [17,18]. The susceptibility
of lys-7 knockout animals to S. aureus and P. aeruginosa was
indistinguishable from that of the wild type strain (Figs 1B and C),
suggesting that the loss of LYS-7 does not damage the worm
immune response to all pathogens. In marked contrast, however,
lys-7 knockout animals are strongly resistant to killing by S.
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independent, allele: lys-7(ok1385) (Figs S1C and D), and an
additional S. Typhimurium strain 14028 s (Fig S1E), indicating
that this phenomenon, which we refer to as ‘‘balanced immunity’’,
is not allele or strain specific.
Resistance to S. Typhimurium is mediated by genetic
compensation
We considered that the loss of lys-7 may trigger compensatory
up-regulation of other genes that result in the observed resistance
to S. Typhimurium. Expression analysis identified only four genes
that are significantly up-regulated in both lys-7 knockout strains
(ok1384 and ok1385) in comparison to wild type animals: abl-1
(2.6560.94 fold up-regulation), fat-5 (1.8260.15 fold up-regula-
tion), clec-60 (1.5960.08 fold up-regulation), and rga-6
(1.9260.089 fold up-regulation).
We obtained knockout strains for each of these genes and
tested their susceptibility to killing by C. neoformans and S.
Typhimurium (Figs 2A and B). Remarkably, animals lacking
either abl-1 or rga-6 were hypersensitive to C. neoformans but
resistant to S. Typhimurium infection; a survival pattern
which phenocopies that of the lys-7 knockout animals. fat-5
knockout animals show slight resistance to S. Typhimurium but
a normal susceptibility to C. neoformans,w h i l s tclec-60 mutant
animals are indistinguishable from wild type animals in their
survival following exposure to either pathogen.
We next used qRT-PCR to assess whether lys-7 expression was
altered in these knockout animals under normal culture condi-
tions. lys-7 expression remained unchanged in fat-5, clec-60 and rga-
6 knockout animals, but, interestingly, was significantly up-
regulated in abl-1 mutants (Fig 2C). Thus lys-7 and abl-1 show
reciprocal regulation of expression and identical loss-of-function
phenotypes upon infectious challenge.
Importantly, the abl-1 phenotype is not allele specific (Figs S2A
and B) nor do abl-1 animals show reduced lifespan, brood size or
resistance to S. aureus infection (Figs S2C, D and E), indicating a
specific role for ABL-1 in mediating immunological tolerance to S.
Typhimurium.
Reciprocal expression of lys-7 and abl-1 is required for
tolerance to S. Typhimurium
To investigate this compensatory mechanism further, we
generated a series of double mutants for lys-7 and the three
candidate genes (abl-1, fat-5 and rga-6) identified by resistance
analysis, and tested their susceptibility to infection with C.
neoformans and S. Typhimurium. Whilst lys-7(ok1384);abl-1(ok171)
Figure 1. lys-7 mutant nematodes are hypersensitive to cryptococcal infection, but resistant to S. Typhimurium. lys-7 knockout animals
show reduced survival relative to N2 upon infection with C. neoformans (A); p,0.0001, [lys-7(ok1384) n=106; N2 n=151], but wild type sensitivity to
S. aureus (B) and P. aeruginosa (C), p.0.05, [lys-7(ok1384) n=131; N2 n=168] and p.0.2, [lys-7(ok1384) n=104; N2 n=111] respectively. Surprisingly,
however, lys-7 mutant animals exhibit enhanced resistance to S. Typhimurium (D); p,0.0001, [lys-7(ok1384) n=191; N2 n=242].
doi:10.1371/journal.pone.0016839.g001
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resistance to S. Typhimurium exhibited by both single mutants
was completely abolished (Figs 3A and B). In contrast however, the
other double mutants (rga-6(ok1316);lys-7(ok1384) and fat-
5(ok460);lys-7(ok1384)) remained sensitive to killing by C. neoformans
and resistant to killing by S. Typhimurium (Figs 3C and D),
suggesting that the loss of lys-7 is dominant in these animals,
although we note that the degree of resistance has been slightly
reduced in the case of rga-6. Taken together, these data indicate
that abl-1 and lys-7 act together to regulate S. Typhimurium
resistance in C. elegans.
S. Typhimurium burden in the mutant animals is
unchanged from wild type
We questioned whether the resistance of lys-7(ok1384) and abl-
1(ok171) mutant animals to S. Typhimurium was due to a lower
bacterial load within infected animals. To test this, we exposed
wild type, lys-7 and abl-1 animals to S. Typhimurium L1019, a
GFP-expressing derivative of SL1344 (kindly provided by Jessica
Blair and Laura Piddock, University of Birmingham) and
quantified infectious burden over time both through viable counts
(Fig 4A) and microscopy (Fig S3). We found no consistent
difference between any of the strains.
We also considered the possibility that lys-7 and abl-1 knockout
animals may be better able to limit S. Typhimurium proliferation
within the gut. To test this, we restricted the animals’ exposure to
the pathogen to just six hours and then shifted them to the normal
feeding bacteria E. coli OP50 (a regime previously shown to lead to
persistent colonisation [17]). Under these conditions both lys-7 and
abl-1 animals retain their strong tolerance phenotypes (Fig 4B), but
we observed no difference in S. Typhimurium colonisation
between the mutants and wild type animals microscopically (Fig
S4). Thus the enhanced survival of lys-7 and abl-1 knockout
animals is due to an increased tolerance of S. Typhimurium within
the gut, rather than resistance to infection or limitation of bacterial
growth.
Figure 2. abl-1 and rga-6 mutant animals phenocopy lys-7 susceptibility patterns. Knockout C. elegans strains for the four genes which were
identified by a microarray to be up-regulated in the lys-7 mutant background were assayed for survival upon infection with both C. neoformans and S.
Typhimurium. The survival of abl-1(ok171) and rga-6(ok1316) animals was significantly lower than wild type animals upon C. neoformans infection (A),
p,0.0001 and p,0.01 respectively. The remaining animals were unchanged from wild type survival, p.0.2, [N2 n=186; abl-1(ok171) n=130; rga-
6(ok1316) n=192; fat-5(ok460) n=100; clec-60(tm2319) n=110]. abl-1(ok171), rga-6(ok1316) and fat-5(tm420), but not clec-60(tm2319), animals
exhibited enhanced resistance to S. Typhimurium (B), p,0.0001 in each case, [N2 n=170; abl-1(ok171) n=222; rga-6(ok1316) n=100; fat-5(ok460)
n=162; clec-60(tm2319) n=125]. (C) abl-1 mutant animals up-regulate lys-7 expression (average induction of 6.8 fold; p,0.05), whereas lys-7
expression is unchanged from wild type in the remaining mutant backgrounds. Data represent the mean expression of three independent
experiments, 6 S.E.M.
doi:10.1371/journal.pone.0016839.g002
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The lysozyme LYS-7 has been well-described in C. elegans as an
essential antimicrobial molecule [7,8,9,10]. Here we show that
LYS-7 protects animals against C. neoformans-mediated killing, a
function that is presumably attributable to the secondary chitinase
(anti-fungal) activity exhibited by most lysozymes [19]. Remark-
ably, however, lys-7 acts as a susceptibility factor for S.
Typhimurium killing, as the loss of lys-7 more than doubles the
median survival of Salmonella-challenged animals.
In a manner similar to the lys-7 mutant animals, we find that abl-1
mutant worms are hypersusceptible to killing by C. neoformans.S i n c e
these animals show up-regulation of lys-7, a gene that we demonstrate
to be important for cryptococcal resistance, we therefore conclude
that ABL-1 regulates immunity at two levels (by the up-regulation of
lys-7 and by a second, lys-7 independent pathway), both of which are
required for wild type resistance to C. neoformans.
In vertebrates this phenomenon of immunological trade-off,
whereby resistance to one class of pathogens comes at the cost of
increased susceptibility to others, has been well documented
[20,21,22]. Recently, analogous balance phenotypes have been
described in Drosophila [23,24,25,26,27]. However, our finding of a
susceptibility trade-off in C. elegans, mediated by the activity of
LYS-7 and the tyrosine kinase ABL-1, is the first report of such a
phenotype in nematodes and, as such, has significant implications
for our understanding of the evolution of innate immunity in
animals.
Materials and Methods
C. elegans and pathogen strains used
The strains used for this work are listed in Methods S1 and
Table S1. Nematodes were cultured using standard methods as
described previously [28,29].
Figure 3. lys-7;abl-1 double mutants suppress the tolerance resistance phenotype. lys-7(ok1384)abl-1(ok171) double mutants remain
hypersensitive to C. neoformans (A), similar to their corresponding single mutants; p,0.0001, [abl-1(ok171)lys-7(ok1384) n=133; N2 n=150], but the
resistance exhibited by the single mutants to S. Typhimurium infection (B) has been completely suppressed; p.0.2, [abl-1(ok171)lys-7(ok1384) n=110;
N2 n=94]. Double mutants between lys-7 and fat-5 or lys-7 and rga-6 were hypersensitive to C. neoformans infection (C), p,0.0001 in both cases, [N2
n=207; lys-7(ok1384)fat-5(tm420) n=100; lys-7(ok1384)rga-6(ok1316) n=100]. Similarly, the resistance to S. Typhimurium exhibited by the lys-7
knockout strain was either unaltered (fat-5) or only slightly reduced (rga-6) by these secondary mutations (D), [N2 n=170; lys-7(ok1384)fat-5(tm420)
n=100; lys-7(ok1384)rga-6(ok1316) n=100].
doi:10.1371/journal.pone.0016839.g003
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20 ml of an overnight bacterial/fungal culture was inoculated
onto 6 cm NGM plates, supplemented with the appropriate
antibiotic if required, and lawns were allowed to grow at room
temperature for 12 h. 15–30 animals at the L4 stage were picked
onto each plate and subsequently transferred to newly seeded
plates every 1–2 days. Survival was monitored every 24 hr and
death was determined as a failure to respond to mechanical
stimulus.
C. elegans bacterial CFU analysis
Infection load was assessed through viable counts. The assay
was modified from [30]; L4 animals were infected with S.
Typhimurium strain L1019. At each timepoint, ten replicates of
six animals each were incubated in 200 ml M9 buffer containing
25 mM levamisole hydrochloride (Sigma) and ampicillin (1 mg/
ml) for one hour. The ampicillin was subsequently removed by
three washes of 200 ml M9 with 25 mM levamisole hydrochloride.
Animals were lysed in this buffer for 10 s using the Precellys 24
Lysis and Homogeniser. Lysates were serially diluted in M9 and
plated onto LB plates containing kanamycin (30 mg/ml) to select
for L1019. Colonies were counted by eye and scaled to the original
concentration per nematode.
S. Typhimurium persistence analysis
L4 animals were exposed to S. Typhimurium SL1344 on plates
for six hours before being washed 3 times in M9 solution and
shifted onto NGM plates seeded with 20 ml OP50 at 25uC.
Animals were transferred to newly seeded plates every 1–2 days
and scored for death (failure to respond to mechanical stimulus)
every 1–2 days.
RNA isolation, cDNA preparation and qRT-PCR
Total RNA was extracted from each strain on three
independent occasions. Full plates of staged L4 animals were
homogenised in 400 ml lysis buffer (Qiagen) using the Precellys
24 Lysis and Homogeniser. RNA was isolated from these lysates
using the ‘‘RNeasy Mini Kit’’ (Qiagen) according to the
manufacturer’s instructions. RNA samples were treated with
‘‘DNA-free’’ (Ambion, Inc.) and subsequently quantified using
the Nanodrop ND1000 microspectrophotometer (NanoDrop
Technologies, Inc.). cDNA was synthesised using SuperScript II
(Invitrogen) with random primers (Promega) in a SensoQuest
Labcycler, assuming a 1:1 conversion. The absence of genomic
DNA was confirmed by PCR of these cDNA products (34
cycles: 94uC, 25 s; 55uC, 30 s; 72uC, 60 s), the amplimers of
which were separated by electrophoresis on a 2.5% agarose gel.
Quantitative real-time PCR (qRT-PCR) was performed on each
cDNA sample in triplicate using 2x SensiMix (dU) SYBR Green
kit (Quantace), but with a reaction volume of 25 ml. In each
reaction MgCl2 had a final concentration of 3 mM, primers
(sequences can be found in Table S2) were used at 20 mM and
a template concentration of 2.5 ng was used. Each plate was
run on an ABI Prism 7000 instrument with the following
thermal cycling conditions: 37uC, 10 min; 95uC, 10 min; 95uC,
15 s; 55uC, 30 s; 72uC, 30 s; steps 3–5 were repeated for 40
cycles.
Statistical analysis
All survival replicates were checked for consistency prior to
being combined into single survival curves in Microsoft Excel
using a macro-based template to calculate Kaplan-Meier survival
probabilities every 24 hours. Each curve represents at least three
independent experiments. Differences in survival were tested with
a non-parametric log-rank analysis and assessed for significance
using Chi squared. P-values below 0.05, after correcting for
multiplicity, were taken to be significant. The data in the survival
curves are presented as the proportion of animals surviving. The
bacterial CFU analysis was carried out in Microsoft Excel and
subsequently tested for significance using the Students’ T-test (2
tailed, equal variance). The qRT-PCR was normalised to gpd-3
expression using the Comparative Ct method in Microsoft Excel
[31,32], and tested for statistical significance using the Students’ T-
test (2 tailed, equal variance, paired).
Figure 4. lys-7 and abl-1 mutant animals are tolerant of S. Typhimurium infection. (A) Bacterial load was assessed through viable counts.
There was no difference between any of the strains, p.0.2, although there is a slight disparity between abl-1(ok171) and lys-7(ok1384) on day 4 of the
infection, p,0.05, [abl-1(ok171) n=60, lys-7(ok1384) n=60; N2 n=60]. (B) lys-7(ok1384) and abl-1(ok171) single mutants are tolerant to S.
Typhimurium infection following a six-hour exposure, p,0.01 and p,0.0001 respectively, [lys-7(ok1384) n=90; abl-1(ok171) n=86; N2 n=96].
doi:10.1371/journal.pone.0016839.g004
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Figure S1 lys-7 mutant nematodes do not differ from
wild type animals in lifespan or brood size and the
resistance phenotype is maintained with alternative
Salmonella and C. elegans strains. lys-7 knockout animals
have a normal lifespan in non-infectious conditions (A); p.0.2,
[lys-7(ok1384) n=129; N2 n=199], and are unimpaired in their
ability to produce young (B), data represent mean 6 s.d. A further
independent lys-7 knockout strain (ok1385) showed the same
balance phenotype, being hypersensitive to C. neoformans (C),
p,0.001, [lys-7(ok1385) n=101; N2 as Figure 1A] and resistant to
S. Typhimurium SL1344 (D), p,0.0001, [lys-7(ok1385) n=169;
N2 as Figure 1D]. Moreover, the lys-7(ok1384) mutant worms
exhibited the same enhanced resistance to infection with S.
Typhimurium 14028 s (E) in comparison to the wild type strain;
p,0.01, [lys-7(ok1385) n=123; N2 n=120].
(EPS)
Figure S2 abl-1 mutant nematodes do not show a
reduction in lifespan or brood size and the resistance
phenotype is maintained with alternative Salmonella
and C. elegans strains. Two further independent abl-1
knockout strains showed the same balance phenotype, being
hypersensitive to C. neoformans (A), p,0.0001 in both cases, [abl-
1(n1961) n=150; abl-1(n1963) n=152; N2 n=325] and resistant
to S. Typhimurium SL1344 (B), p,0.0001 in both cases, [abl-
1(n1961) n=150; abl-1(n1963) n=127; N2 n=278]. abl-1
knockout animals have a normal lifespan under non-infectious
conditions (C); p.0.2, [abl-1(ok171) n=142; N2 n=159], and are
unimpaired in their ability to produce young (D), data represent
mean 6 s.d. Further, no difference between abl-1(ok171) and wild
type survival upon S. aureus infection was detected (E), p.0.2, [abl-
1(ok171) n=120; N2 as Figure 1B]. Moreover, the abl-1 mutant
worms exhibited the same enhanced resistance to infection with S.
Typhimurium 14028 s (E) in comparison to the wild type strain;
p,0.001, [abl-1(ok171) n=90; N2 n=112].
(EPS)
Figure S3 Microscopic analysis of a constant S. Typhi-
murium infection in C. elegans. Bacterial load of each C.
elegans strain was assessed microscopically using a GFP-expressing
S. Typhimurium, strain L1019, across a five day infection. No
difference in infection load was identified between the strains.
(EPS)
Figure S4 Microscopic analysis of a six hour S.
Typhimurium infection in C. elegans. Bacterial load of
each C. elegans strain was assessed microscopically using a GFP-
expressing S. Typhimurium, strain L1019, across a five day
infection. No difference in infection load was identified between
the strains.
(EPS)
Table S1 Bacterial and fungal strains and their respec-
tive growth requirements.
(DOC)
Table S2 Primer Sequences.
(DOC)
Methods S1 Methodology for those data presented in
supporting information.
(DOC)
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